Crescendo CEO says Takeda’s decision to exercise licence option is validation of its immunotherapy platform

Crescendo CEO says Takeda’s decision to exercise licence option is validation of its immunotherapy platform

APM Health Europe

Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018

Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018

View PDF